赞比亚疟疾规划性群体服药对发病率影响的评估
赞比亚南部省2016年启动以双氢青蒿素哌喹为工具的规划性群体服药(pMDA),两轮覆盖率为70%和57%。
要点
- 干预季末发病率回升,无地区实现传播阻断。
- 常规数据可用于规划性干预效果评估。
核心结论
- 在低传播且病媒控制覆盖不理想的地区,开展1年覆盖不完美的pMDA显著降低疟疾发病率,但消除仍需额外工具。
研究设计与样本
- 中断时间序列与比较组分析,使用卫生机构服务 catchment area(HFCA)级月度发病率数据,负二项模型广义估计方程。
- pMDA组为发病率略高于50例/1000人/年阈值的10个HFCA,比较组为略低于阈值的20个HFCA。
主要发现
- 发病率在季末出现回升。
- 无HFCA实现传播阻断。
关键数值与推荐
- pMDA在年发病率大于50例/1000人的HFCA开展。
- 两轮双氢青蒿素哌喹pMDA间隔2个月,覆盖率分别为70%和57%。
临床怎么用
- 在低传播且病媒控制不理想地区可考虑pMDA作为降低发病率的补充手段。
- 应预期pMDA后发病率可能回升,需结合其他消除工具。
- 可利用常规监测数据评估pMDA等项目干预效果。
局限性
- pMDA覆盖不完美(第二轮57%)。
- 研究仅评估1年效果。
- 为观察性设计,可能存在残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In 2016, the Zambian National Malaria Elimination Centre started programmatic mass drug administration (pMDA) campaigns with dihydroartemisinin-piperaquine as a malaria elimination tool in Southern Province. Two rounds were administered, 2 months apart (coverage 70% and 57%, respectively). We evaluated the impact of 1 year of pMDA on malaria incidence using routine data. METHODS: We conducted an interrupted time series with comparison group analysis on monthly incidence data collected at the health facility catchment area (HFCA) level, with a negative binomial model using generalized estimating equations. Programmatic mass drug administration was conducted in HFCAs with greater than 50 cases/1000 people per year. Ten HFCAs with incidence rates marginally above this threshold (pMDA group) were compared with 20 HFCAs marginally below (comparison group). RESULTS: The pMDA HFCAs saw a 46% greater decrease in incidence at the time of intervention than the comparison areas (incidence rate ratio = 0.536; confidence interval = 0.337-0.852); however, incidence increased toward the end of the season. No HFCAs saw a transmission interruption. CONCLUSIONS: Programmatic mass drug administration, implemented during 1 year with imperfect coverage in low transmission areas with suboptimal vector control coverage, significantly reduced incidence. However, elimination will require additional tools. Routine data are important resources for programmatic impact evaluations and should be considered for future analyses.
引用
- Fraser M, Miller JM, Silumbe K, et al. Evaluating the Impact of Programmatic Mass Drug Administration for Malaria in Zambia Using Routine Incidence Data. J Infect Dis. 2022. PMID: 32691047. doi:10.1093/infdis/jiaa434
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。